| Product Code: ETC9686422 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Hemophilia A Treatment Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Hemophilia A Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Hemophilia A Treatment Market - Industry Life Cycle |
3.4 Thailand Hemophilia A Treatment Market - Porter's Five Forces |
3.5 Thailand Hemophilia A Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand Hemophilia A Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Thailand Hemophilia A Treatment Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Thailand Hemophilia A Treatment Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.9 Thailand Hemophilia A Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.10 Thailand Hemophilia A Treatment Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
4 Thailand Hemophilia A Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about hemophilia A and its treatment options in Thailand |
4.2.2 Technological advancements in hemophilia A treatment, leading to improved therapies |
4.2.3 Growing healthcare infrastructure and access to treatment facilities in Thailand |
4.3 Market Restraints |
4.3.1 High cost associated with hemophilia A treatment and therapies |
4.3.2 Limited availability of specialized healthcare professionals for hemophilia A treatment in Thailand |
4.3.3 Regulatory challenges and approval processes for new hemophilia A treatments in the market |
5 Thailand Hemophilia A Treatment Market Trends |
6 Thailand Hemophilia A Treatment Market, By Types |
6.1 Thailand Hemophilia A Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Hemophilia A Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Thailand Hemophilia A Treatment Market Revenues & Volume, By Severe, 2021- 2031F |
6.1.4 Thailand Hemophilia A Treatment Market Revenues & Volume, By Moderate, 2021- 2031F |
6.1.5 Thailand Hemophilia A Treatment Market Revenues & Volume, By Mild, 2021- 2031F |
6.2 Thailand Hemophilia A Treatment Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Thailand Hemophilia A Treatment Market Revenues & Volume, By Recombinant Factor Concentrates, 2021- 2031F |
6.2.3 Thailand Hemophilia A Treatment Market Revenues & Volume, By Plasma-derived Factor Concentrates, 2021- 2031F |
6.2.4 Thailand Hemophilia A Treatment Market Revenues & Volume, By Extended Half-life Products, 2021- 2031F |
6.3 Thailand Hemophilia A Treatment Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Thailand Hemophilia A Treatment Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.3.3 Thailand Hemophilia A Treatment Market Revenues & Volume, By Adult, 2021- 2031F |
6.4 Thailand Hemophilia A Treatment Market, By Diagnosis |
6.4.1 Overview and Analysis |
6.4.2 Thailand Hemophilia A Treatment Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.4.3 Thailand Hemophilia A Treatment Market Revenues & Volume, By Fibrinogen Test, 2021- 2031F |
6.4.4 Thailand Hemophilia A Treatment Market Revenues & Volume, By Factor VIII and Factor IX Tests, 2021- 2031F |
6.4.5 Thailand Hemophilia A Treatment Market Revenues & Volume, By Prothrombin Time (PT), 2021- 2031F |
6.4.6 Thailand Hemophilia A Treatment Market Revenues & Volume, By Complete Blood Count (CBC), 2021- 2031F |
6.5 Thailand Hemophilia A Treatment Market, By Treatment |
6.5.1 Overview and Analysis |
6.5.2 Thailand Hemophilia A Treatment Market Revenues & Volume, By Prophylaxis, 2021- 2031F |
6.5.3 Thailand Hemophilia A Treatment Market Revenues & Volume, By On Demand, 2021- 2031F |
6.6 Thailand Hemophilia A Treatment Market, By Therapy |
6.6.1 Overview and Analysis |
6.6.2 Thailand Hemophilia A Treatment Market Revenues & Volume, By Factor Replacement Therapy, 2021- 2031F |
6.6.3 Thailand Hemophilia A Treatment Market Revenues & Volume, By Non-factor Replacement Therapy, 2021- 2031F |
7 Thailand Hemophilia A Treatment Market Import-Export Trade Statistics |
7.1 Thailand Hemophilia A Treatment Market Export to Major Countries |
7.2 Thailand Hemophilia A Treatment Market Imports from Major Countries |
8 Thailand Hemophilia A Treatment Market Key Performance Indicators |
8.1 Number of hemophilia A patients diagnosed and receiving treatment in Thailand |
8.2 Adoption rate of new hemophilia A treatment options in the market |
8.3 Average time taken for hemophilia A patients to access treatment facilities and receive care |
8.4 Patient satisfaction levels with hemophilia A treatment services provided |
8.5 Number of clinical trials and research studies conducted on hemophilia A treatment in Thailand |
9 Thailand Hemophilia A Treatment Market - Opportunity Assessment |
9.1 Thailand Hemophilia A Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand Hemophilia A Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Thailand Hemophilia A Treatment Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Thailand Hemophilia A Treatment Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.5 Thailand Hemophilia A Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.6 Thailand Hemophilia A Treatment Market Opportunity Assessment, By Therapy, 2021 & 2031F |
10 Thailand Hemophilia A Treatment Market - Competitive Landscape |
10.1 Thailand Hemophilia A Treatment Market Revenue Share, By Companies, 2024 |
10.2 Thailand Hemophilia A Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here